I am/have/had
I am looking for
Advanced Filters
Found 247 clinical trials
Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3
Primary Objective: Evaluate the safety and pharmacokinetics of eliglustat in pediatric patients (2 to <18 years old). Secondary Objective: Evaluate the efficacy of eliglustat and quality of life in pediatric patients (2 to <18 years old).
cerezyme
alglucerase
enzyme assay
imiglucerase
gaucher disease
- 0 views
- 19 Feb, 2024
- 19 locations
